Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,337 warrant series at 1,059 companies. 778 in the money, 58 expiring in the next 30 days, 38 waiting on a stockholder vote or other stated condition, 0 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| November 2024 Purchaser Warrants | $0.5711 | $18.5M | 10-K, Apr 30, 2026Dilution tabAs of Nov 1, 2026 | ||||||||
| October 2025 Placement Agent Warrants | $0.5711 | $18.5M | 10-K, Apr 30, 2026Dilution tabAs of Nov 1, 2026 | ||||||||
| October 2025 Warrants | $0.5711 | $18.5M | 10-K, Apr 30, 2026Dilution tabAs of Nov 1, 2026 | ||||||||
| Strategic Advisory Warrants - Tranche 1 ($3.00) | $0.5711 | $18.5M | 10-K, Apr 30, 2026Dilution tabAs of Nov 1, 2026 | ||||||||
| Strategic Advisory Warrants - Tranche 4 ($12.00) | $0.5711 | $18.5M | 10-K, Apr 30, 2026Dilution tabAs of Nov 1, 2026 | ||||||||
| IPO Underwriter Warrants (US Tiger) – April 23, 2024 tranche | $1.11 | $18.5M | 20-F, Apr 23, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| IPO Underwriter Warrants (US Tiger) – April 30, 2024 over-allotment tranche | $1.11 | $18.5M | 20-F, Apr 23, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| Warrants to purchase ordinary shares outstanding at December 31, 2025 (unitemised, pre-restructuring) | $1.24 | $18.1M | 20-F, Apr 30, 2026Dilution tabAs of Oct 4, 2026 | ||||||||
| Perceptive Credit Holdings IV, LP Warrant (Warrant Certificate No. P-1, issued October 1, 2026) | $0.1832 | $18.1M | 8-K, Oct 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Legacy pre-2024 warrants (residual, undecomposed) | $0.9350 | $17.9M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Placement Agent Warrants (H.C. Wainwright designees, September 2026) | $0.9350 | $17.9M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Series A Common Warrants (September 2026 Private Placement) | $0.9350 | $17.9M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Series B Common Warrants (September 2026 Private Placement) | $0.9350 | $17.9M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Service Provider Warrant – $4.00 tranche (April 2024) | $0.9350 | $17.9M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Service Provider Warrant – $5.00 tranche (April 2024) | $0.9350 | $17.9M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Service Provider Warrant – $6.00 tranche (April 2024) | $0.9350 | $17.9M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| August 31, 2022 services warrants ($1.20, expiring August 31, 2027) | $0.3800 | $17.8M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Innoven Warrant (assumed CCT warrant issued to Innoven Capital China) | $8.95 | $17.6M | 20-F, Apr 27, 2026Dilution tabAs of Oct 5, 2026 | ||||||||
| Public Warrants (assumed Prime Impact public warrants, $11.50, CCGWW) | $8.95 | $17.6M | 424B3, Jun 3, 2025Dilution tabAs of Oct 5, 2026 | ||||||||
| Sponsor Warrants (assumed Prime Impact private placement warrants, $11.50) | $8.95 | $17.6M | 424B3, Jun 3, 2025Dilution tabAs of Oct 5, 2026 | ||||||||
| Common stock warrants (aggregate, not itemised by series) | $0.6110 | $17.4M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Warrants issued in prior financings (legacy warrants, aggregate) | $4.72 | $17.3M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| April 2025 Pre-Funded Warrant | $3.75 | $17.2M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Placement Agent Warrants (July 2024) | $3.75 | $17.2M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Registered direct offering 1 (Wainwright Warrants, February 1, 2023) | $3.75 | $17.2M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Registered direct offering 2 (Wainwright Warrants, February 2, 2023) | $3.75 | $17.2M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Registered direct offering 3 (Wainwright Warrants, February 3, 2023) | $3.75 | $17.2M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Series A Warrants (July 2024) | $3.75 | $17.2M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Series B Warrants (July 2024) | $3.75 | $17.2M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Loan Warrant (K2 HealthVentures term loan warrant, $1.95) | $0.2301 | $16.6M | 10-Q, Oct 26, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Placement agent warrants – $12.50 | $3.68 | $16.5M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Placement agent warrants – $4.00 | $3.68 | $16.5M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Placement agent warrants – $4.62 (2022 private placement) | $3.68 | $16.5M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Placement agent warrants – $9.00 | $3.68 | $16.5M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Warrants issued to certain 5% stockholders – $15.00 | $3.68 | $16.5M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Hudson Global Ventures Common Stock Purchase Warrant (Equity Purchase Agreement commitment warrant, Sept 17, 2026) | $0.4001 | $16.5M | 424B5, Oct 19, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Legacy warrants outstanding prior to 2026 (aggregate) | $2.55 | $16.4M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| March 2025 Warrants (SATS Warrant) | $0.2940 | $16.2M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Public Warrants (legacy FTAC Emerald, FLDDW) | $0.2940 | $16.2M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Series A Warrants (December 2024 SPA / June 2025 Amended Investor Note) | $0.2940 | $16.2M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| August 2026 Ordinary Warrants ($6.10) | $3.36 | $16.1M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| August 2026 Pre-Funded Warrants | $3.36 | $16.1M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| December 2024 Series F Warrants ($15.75) | $3.36 | $16.1M | 10-K, Mar 26, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| December 2024 Series G Warrants ($15.75) | $3.36 | $16.1M | 10-K, Mar 26, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Legacy warrants residual (March 2024 Series D/E, pre-2024 warrants, incl. December 2024 repriced warrants) | $3.36 | $16.1M | 10-K, Mar 26, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| October 2025 Pre-Funded Warrants | $3.36 | $16.1M | 424B3, Sep 25, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| October 2025 Series H Warrants ($9.075) | $3.36 | $16.1M | 10-K, Mar 26, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| October 2025 Series I Warrants ($10.3125) | $3.36 | $16.1M | 10-K, Mar 26, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| October 2025 Series J Warrants ($12.375) | $3.36 | $16.1M | 10-K, Mar 26, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| October 2025 Series K Warrants ($12.375) | $3.36 | $16.1M | 10-K, Mar 26, 2026Dilution tabAs of Nov 10, 2026 |
CELUCelularity Inc.$0.5711Last price
November 2024 Purchaser Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$18.5M
CELUCelularity Inc.$0.5711Last price
October 2025 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$18.5M
CELUCelularity Inc.$0.5711Last price
October 2025 Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$18.5M
CELUCelularity Inc.$0.5711Last price
Strategic Advisory Warrants - Tranche 1 ($3.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$18.5M
CELUCelularity Inc.$0.5711Last price
Strategic Advisory Warrants - Tranche 4 ($12.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$18.5M
TRSGTungray Technologies Inc Class A Ordinary Shares$1.11Last price
IPO Underwriter Warrants (US Tiger) – April 23, 2024 tranche
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$18.5M
TRSGTungray Technologies Inc Class A Ordinary Shares$1.11Last price
IPO Underwriter Warrants (US Tiger) – April 30, 2024 over-allotment tranche
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$18.5M
ARBKArgo Blockchain plc American Depositary Shares$1.24Last price
Warrants to purchase ordinary shares outstanding at December 31, 2025 (unitemised, pre-restructuring)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$18.1M
DCGODocGo Inc.$0.1832Last price
Perceptive Credit Holdings IV, LP Warrant (Warrant Certificate No. P-1, issued October 1, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$18.1M
BSEMBioStem Technologies, Inc.$0.9350Last price
Legacy pre-2024 warrants (residual, undecomposed)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$17.9M
BSEMBioStem Technologies, Inc.$0.9350Last price
Placement Agent Warrants (H.C. Wainwright designees, September 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$17.9M
BSEMBioStem Technologies, Inc.$0.9350Last price
Series A Common Warrants (September 2026 Private Placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$17.9M
BSEMBioStem Technologies, Inc.$0.9350Last price
Series B Common Warrants (September 2026 Private Placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$17.9M
BSEMBioStem Technologies, Inc.$0.9350Last price
Service Provider Warrant – $4.00 tranche (April 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$17.9M
BSEMBioStem Technologies, Inc.$0.9350Last price
Service Provider Warrant – $5.00 tranche (April 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$17.9M
BSEMBioStem Technologies, Inc.$0.9350Last price
Service Provider Warrant – $6.00 tranche (April 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$17.9M
STQNStrategic Acquisitions, Inc.$0.3800Last price
August 31, 2022 services warrants ($1.20, expiring August 31, 2027)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$17.8M
CCGCheche Group Inc. Class A Ordinary Shares$8.95Last price
Innoven Warrant (assumed CCT warrant issued to Innoven Capital China)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$17.6M
CCGCheche Group Inc. Class A Ordinary Shares$8.95Last price
Public Warrants (assumed Prime Impact public warrants, $11.50, CCGWW)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$17.6M
CCGCheche Group Inc. Class A Ordinary Shares$8.95Last price
Sponsor Warrants (assumed Prime Impact private placement warrants, $11.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$17.6M
CVRXCVRx, Inc.$0.6110Last price
Common stock warrants (aggregate, not itemised by series)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$17.4M
CLROClearOne, Inc.$4.72Last price
Warrants issued in prior financings (legacy warrants, aggregate)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$17.3M
MSGMMotorsport Games Inc.$3.75Last price
April 2025 Pre-Funded Warrant
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$17.2M
MSGMMotorsport Games Inc.$3.75Last price
Placement Agent Warrants (July 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$17.2M
MSGMMotorsport Games Inc.$3.75Last price
Registered direct offering 1 (Wainwright Warrants, February 1, 2023)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$17.2M
MSGMMotorsport Games Inc.$3.75Last price
Registered direct offering 2 (Wainwright Warrants, February 2, 2023)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$17.2M
MSGMMotorsport Games Inc.$3.75Last price
Registered direct offering 3 (Wainwright Warrants, February 3, 2023)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$17.2M
MSGMMotorsport Games Inc.$3.75Last price
Series A Warrants (July 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$17.2M
MSGMMotorsport Games Inc.$3.75Last price
Series B Warrants (July 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$17.2M
ABOSAcumen Pharmaceuticals, Inc.$0.2301Last price
Loan Warrant (K2 HealthVentures term loan warrant, $1.95)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$16.6M
INLXIntellinetics, Inc.$3.68Last price
Placement agent warrants – $12.50
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$16.5M
INLXIntellinetics, Inc.$3.68Last price
Placement agent warrants – $4.00
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$16.5M
INLXIntellinetics, Inc.$3.68Last price
Placement agent warrants – $4.62 (2022 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$16.5M
INLXIntellinetics, Inc.$3.68Last price
Placement agent warrants – $9.00
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$16.5M
INLXIntellinetics, Inc.$3.68Last price
Warrants issued to certain 5% stockholders – $15.00
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$16.5M
GOAIEva Live, Inc.$0.4001Last price
Hudson Global Ventures Common Stock Purchase Warrant (Equity Purchase Agreement commitment warrant, Sept 17, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$16.5M
BGDEBig Digital Energy, Inc.$2.55Last price
Legacy warrants outstanding prior to 2026 (aggregate)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$16.4M
FLDFold Holdings, Inc.$0.2940Last price
March 2025 Warrants (SATS Warrant)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$16.2M
FLDFold Holdings, Inc.$0.2940Last price
Public Warrants (legacy FTAC Emerald, FLDDW)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$16.2M
FLDFold Holdings, Inc.$0.2940Last price
Series A Warrants (December 2024 SPA / June 2025 Amended Investor Note)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$16.2M
QNRXQuoin Pharmaceuticals, Ltd.$3.36Last price
August 2026 Ordinary Warrants ($6.10)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$16.1M
QNRXQuoin Pharmaceuticals, Ltd.$3.36Last price
August 2026 Pre-Funded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$16.1M
QNRXQuoin Pharmaceuticals, Ltd.$3.36Last price
December 2024 Series F Warrants ($15.75)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$16.1M
QNRXQuoin Pharmaceuticals, Ltd.$3.36Last price
December 2024 Series G Warrants ($15.75)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$16.1M
QNRXQuoin Pharmaceuticals, Ltd.$3.36Last price
Legacy warrants residual (March 2024 Series D/E, pre-2024 warrants, incl. December 2024 repriced warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$16.1M
QNRXQuoin Pharmaceuticals, Ltd.$3.36Last price
October 2025 Pre-Funded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$16.1M
QNRXQuoin Pharmaceuticals, Ltd.$3.36Last price
October 2025 Series H Warrants ($9.075)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$16.1M
QNRXQuoin Pharmaceuticals, Ltd.$3.36Last price
October 2025 Series I Warrants ($10.3125)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$16.1M
QNRXQuoin Pharmaceuticals, Ltd.$3.36Last price
October 2025 Series J Warrants ($12.375)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$16.1M
QNRXQuoin Pharmaceuticals, Ltd.$3.36Last price
October 2025 Series K Warrants ($12.375)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$16.1M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,079 dilution snapshots. 4,883 of 5,337 series state an exercise price and 3,370 an expiry date. 249 record when exercise begins; that count grows as companies are re-extracted. 625 series are left off because their figures could not be restated for a stock split. 19 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.